VP of CMC & Team Build
Clinical Stage Biotech, United Kingdom
The Challenge:
A UK-based clinical stage biotech was preparing to transition from early clinical development into late-stage trials and required a VP of CMC to lead this shift. The role demanded a highly specific skill set within small molecule development, significantly narrowing the available talent pool. Identifying candidates with the right blend of technical depth, leadership capability, and late-stage experience was essential to support the company’s long-term development and manufacturing strategy.
Our Approach:
We partnered with the organisation on a retained basis, investing heavily in research to map all suitable profiles across the UK, Europe, and the US. With most candidates not actively seeking new roles, we made targeted and thoughtful approaches to ensure strong engagement.
This research-led strategy enabled us to build a comprehensive longlist, refine it to a high-quality shortlist, and guide the process closely through interviews and decision-making. We were able to identify the right candidate and secure an accepted offer within just four weeks.